If you’re already depressed, you may need help to make good decisions

In a rather less that surprising finding, a new paper in the Journal of Clinical Oncology reports that men with existing depressive disorders at the time of diagnosis with prostate cancer “are less likely to undergo definitive treatment and experience worse overall survival.” … READ MORE …

USPSTF on PSA screening … a current update …

The U.S. Preventive Services Task Force (USPSTF) has just issued its “Guide to Clinical Preventive Services” for 2014. The publication (which is available on line) includes summary information about screening for prostate cancer. … READ MORE …

Why would prostate cancer be less likely in HIV-positive men?

A new article has explored further previously reported observations that prostate cancer appears to occur with lower incidence in men already diagnosed as positive for human immunodeficiency virus (HIV) than in their HIV-negative, “normal” peers. … READ MORE …

Declining use of the DRE at a large VA medical center: is this a national trend?

Once upon a time (not so very long ago) the digital rectal examination or DRE was the only non-invasive test that a physician could use to assess whether a patient was at risk for localized prostate cancer and/or other prostate problems. Alas, the use of this test appears to be falling out of favor, which is probably not a good thing. … READ MORE …

Can biomarkers in semen accurately detect prostate cancer risk?

According to a research letter accepted for publication in the journal Endocrine-Related Cancer, a group of Australian researchers are suggesting that prostate cancer-specific biomarkers may be identifiable in male semen. … READ MORE …

MRI/TRUS fusion-guided biopsy in a community-like urology practice

A new study just reported in the Journal of Urology provides information on the application of MRI/TRUS fusion-guided prostate biopsy to diagnose prostate cancer in a community-like urology practice (as opposed to a major prostate cancer research center). … READ MORE …

A “proteomic-based” test for prostate cancer prognostic risk

Yet another new test will soon be available that claims to be able to differentiate with relative accuracy between clinically significant and clinically insignificant types of prostate cancer (again based on actual prostate cancer tissue from a biopsy sample or a surgical specimen). … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,133 other followers